Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7578.25 | 459 / 459 | 100% | 46.08 | 1118 / 1118 |
intestine | 100% | 7858.46 | 966 / 966 | 100% | 32.94 | 527 / 527 |
pancreas | 100% | 5317.25 | 328 / 328 | 100% | 33.47 | 178 / 178 |
prostate | 100% | 7587.07 | 245 / 245 | 100% | 39.94 | 502 / 502 |
skin | 100% | 6549.32 | 1809 / 1809 | 100% | 50.11 | 472 / 472 |
stomach | 100% | 5863.53 | 359 / 359 | 100% | 29.69 | 286 / 286 |
uterus | 100% | 7579.77 | 170 / 170 | 100% | 38.36 | 459 / 459 |
lung | 100% | 7134.02 | 578 / 578 | 100% | 35.61 | 1154 / 1155 |
brain | 100% | 4760.40 | 2638 / 2642 | 100% | 55.02 | 705 / 705 |
bladder | 100% | 7835.29 | 21 / 21 | 100% | 33.68 | 503 / 504 |
thymus | 100% | 7768.86 | 653 / 653 | 100% | 40.16 | 603 / 605 |
kidney | 100% | 6594.93 | 89 / 89 | 100% | 38.22 | 898 / 901 |
esophagus | 100% | 7307.96 | 1445 / 1445 | 99% | 25.55 | 182 / 183 |
liver | 100% | 5184.85 | 226 / 226 | 99% | 24.25 | 403 / 406 |
ovary | 100% | 6875.62 | 180 / 180 | 99% | 27.45 | 425 / 430 |
adrenal gland | 100% | 7688.36 | 258 / 258 | 99% | 30.20 | 227 / 230 |
adipose | 100% | 8028.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7345.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.23 | 29 / 29 |
muscle | 100% | 8071.63 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8712.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.19 | 1 / 1 |
heart | 99% | 5474.22 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 43.31 | 79 / 80 |
peripheral blood | 83% | 2971.87 | 768 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904153 | Biological process | negative regulation of retrograde protein transport, ER to cytosol |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0036503 | Biological process | ERAD pathway |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005811 | Cellular component | lipid droplet |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | UBE2G2 |
Protein name | Ubiquitin conjugating enzyme E2 G2 E2 ubiquitin-conjugating enzyme (EC 2.3.2.23) Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2) |
Synonyms | UBC7 |
Description | FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins . In vitro catalyzes 'Lys-48'-linked polyubiquitination . Involved in endoplasmic reticulum-associated degradation (ERAD) . Required for sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its subsequent proteasomal degradation . . |
Accessions | ENST00000330942.9 [P60604-2] P60604 F8WCB9 ENST00000345496.7 [P60604-1] ENST00000491513.5 F8WDB1 ENST00000478200.1 |